載入...
Effect of p53 activation through targeting MDM2/MDM4 heterodimer on T regulatory and effector cells in the peripheral blood of Type 1 diabetes patients
Various immunotherapies for the treatment of type 1 diabetes are currently under investigation. Some of these aim to rescue the remaining beta cells from autoimmune attack caused by the disease. Among the strategies employed, p53 has been envisaged as a possible target for immunomodulation. We studi...
Na minha lista:
| 發表在: | PLoS One |
|---|---|
| Main Authors: | , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Public Library of Science
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988923/ https://ncbi.nlm.nih.gov/pubmed/31995625 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0228296 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|